SCIEX Expands ZenoTOF Platform with AI and Omics Research Innovations
MARLBOROUGH, Mass., June 1, 2026 SCIEX, a Danaher company and a global leader in life science analytical technologies, announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
MARLBOROUGH, Mass., June 1, 2026 SCIEX, a Danaher company and a global leader in life science analytical technologies, announced...
MORRISVILLE, NORTH CAROLINA, UNITED STATES — February 17, 2026 Metabolon announced that its global metabolomics platform has enabled the...
